Xibao Yu

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 10

Top Topics

Acute Myeloid Leukemia

Aortic Dissection

Reactive Oxygen Species

Allogeneic Hematopoietic Stem Cell Transplantation

Top Venues

Clinical and translational medicine

Cell death discovery

ImmunoTargets and therapy

Hematology (Amsterdam, Netherlands)

This page only lists publications with an associated author ORCID identifier.

Publications

Yuchen Li, Yinfeng Gu, Pengyue Yang, Yan Wang, Xibao Yu, Yangqiu Li, Zhenyi Jin, Ling Xu
CD69 is a Promising Immunotherapy and Prognosis Prediction Target in Cancer. ImmunoTargets and therapy 13 (2024)
Xibao Yu, Yuchen Li, Pengyue Yang, Yan Wang, Xuan Liu, Letong Cai, Jing Lai, Yue Zhang, Xianfeng Zha, Grzegorz Krzysztof Przybylski, Ling Xu, Yangqiu Li
BCL11B promotes T-cell acute lymphoblastic leukaemia cell survival via the XRCC5/C11ORF21 axis. Clinical and translational medicine 14 (2) (2024)
Xibao Yu, Yuchen Li, Pengyue Yang, Yan Wang, Xuan Liu, Letong Cai, Jing Lai, Yue Zhang, Xianfeng Zha, Grzegorz Krzysztof Przybylski, Ling Xu, Yangqiu Li
BCL11B promotes T-cell acute lymphoblastic leukaemia cell survival via the XRCC5/C11ORF21 axis. Clinical and translational medicine 14 (2) (2024)
Xibao Yu, Yuchen Li, Pengyue Yang, Yan Wang, Xuan Liu, Letong Cai, Jing Lai, Yue Zhang, Xianfeng Zha, Grzegorz Krzysztof Przybylski, Ling Xu, Yangqiu Li
BCL11B promotes T-cell acute lymphoblastic leukaemia cell survival via the XRCC5/C11ORF21 axis. Clinical and translational medicine 14 (2) (2024)
Xibao Yu, Yan Wang, Jiaxiong Tan, Yuchen Li, Pengyue Yang, Xuan Liu, Jing Lai, Yue Zhang, Letong Cai, Yinfeng Gu, Ling Xu, Yangqiu Li
Inhibition of NRF2 enhances the acute myeloid leukemia cell death induced by venetoclax via the ferroptosis pathway. Cell death discovery 10 (1) (2024)
Xibao Yu, Yan Wang, Jiaxiong Tan, Yuchen Li, Pengyue Yang, Xuan Liu, Jing Lai, Yue Zhang, Letong Cai, Yinfeng Gu, Ling Xu, Yangqiu Li
Inhibition of NRF2 enhances the acute myeloid leukemia cell death induced by venetoclax via the ferroptosis pathway. Cell death discovery 10 (1) (2024)
Yuchen Li, Yinfeng Gu, Pengyue Yang, Yan Wang, Xibao Yu, Yangqiu Li, Zhenyi Jin, Ling Xu
CD69 is a Promising Immunotherapy and Prognosis Prediction Target in Cancer. ImmunoTargets and therapy 13 (2024)
Xibao Yu, Cunte Chen, Yanyun Hu, Kehan Li, Yi-Kai Zhang, Zheng Chen, Dingrui Nie, Rili Gao, Youxue Huang, Mengjun Zhong, Caixia Wang, Shunqing Wang, Yixin Zeng, Yangqiu Li, Chengwu Zeng
High expression of LOC541471, GDAP1, SOD1, and STK25 is associated with poor overall survival of patients with acute myeloid leukemia. Cancer medicine (2023)
Yi-Kai Zhang, Xiangbo Zeng, Xianfeng Zha, Jing Lai, Guangxiao Tan, Shaohua Chen, Xibao Yu, Yangqiu Li, Ling Xu
Correlation of the transcription factors IRF4 and BACH2 with the abnormal NFATC1 expression in T cells from chronic myeloid leukemia patients. Hematology (Amsterdam, Netherlands) 27 (1) (2022)
Xibao Yu, Ardalan Mansouri, Zhuandi Liu, Rili Gao, Kehan Li, Cunte Chen, Youxue Huang, Zheng Chen, Shaohua Chen, Yuhong Lu, Yangqiu Li, Chengwu Zeng, Yixin Zeng
NRF2 activation induced by PML-RARα promotes microRNA 125b-1 expression and confers resistance to chemotherapy in acute promyelocytic leukemia. Clinical and translational medicine 11 (5) (2022)